Get started
Author

Alyssa L. Stockard

Observed names: A. Stockard, A.L. Stockard, Alyssa Stockard
ORCID: 0009-0005-6900-2615
Observed ORCID: 0009-0005-6900-2615
OpenAlex ID: A5114635744
Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells
2024 · Angelina S. Hwang, Jacob A. Kechter, et al. · Journal of Clinical Investigation · 17
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis
2025 · Nicolas Coudray, Michelle C. Juarez, et al. · npj Digital Medicine · 13
PDF
Retrieval Augmented Generation–Enabled Large Language Model for Risk Stratification of Cutaneous Squamous Cell Carcinoma
2025 · Neil K. Jairath, Vartan Pahalyants, et al. · JAMA Dermatology · 8
Multiomic Sequencing of Intermediate- to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes
2025 · Shams Nassir, Miranda Yousif, et al. · Journal of Investigative Dermatology · 6
Assessment of a Deep Learning Model Trained on Permanent Pathology for the Classification of Squamous Cell Carcinoma in Mohs Frozen Sections: Lessons Learned
2025 · Jorge A. Rios-Duarte, Anirudh Choudhary, et al. · Dermatologic Surgery · 2
Immunoediting restricts clonal neoantigens in primary, treatment-naive human tumors
2026 · Elizabeth S. Borden, David Castellano, et al. · Immunity · 1
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
2026 · Alyssa Stockard, Zachary Leibovit-Reiben, et al. · medRxiv · 1
PDF
75318 Deucravacitinib in the Treatment of Pityriasis Rubra Pilaris: A Phase 2 Clinical Trial
2026 · Bryce T. Roberts, Scott Penner, et al. · Journal of the American Academy of Dermatology
77175 Predictors of Treatment Refractory Bullous Pemphigoid
2026 · Scott Penner, Bryce T. Roberts, et al. · Journal of the American Academy of Dermatology
77077 Transcriptomic Analysis of TYK2 Inhibition as a Therapeutic Target in Lichen Planopilaris
2026 · Alyssa L. Stockard, Zachary Leibovit-Reiben, et al. · Journal of the American Academy of Dermatology
Search and Retrieval in Dermatology Atlases of Histopathology Images for Risk Stratification of Cutaneous Squamous Cell Carcinoma
2026 · Ghazal Alabtah, Areej Alsaafin, et al. · medRxiv
PDF
62173 Clinical Characterization and Immune Profiling in Classic Bullous Pemphigoid and Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid
2025 · Zachary Leibovit-Reiben, Alyssa Stockard, et al. · Journal of the American Academy of Dermatology
0784 Skin of color associated genes with worse outcomes in cutaneous squamous cell carcinoma
2025 · Z. Leibovit-Reiben, A.L. Stockard, et al. · Journal of Investigative Dermatology
0130 Utilizing self-supervised machine learning to improve risk stratification in cutaneous squamous cell carcinoma
2025 · A. Choudhary, Z. Leibovit-Reiben, et al. · Journal of Investigative Dermatology
PDF
0468 Deucravacitinib in the treatment of lichen planopilaris: 28-week analysis of patient-reported outcome metrics
2025 · A.L. Stockard, Z. Leibovit-Reiben, et al. · Journal of Investigative Dermatology
PDF
0449 Identifying clinical and molecular phenotypes in bullous pemphigoid and immune checkpoint inhibitor-induced bullous pemphigoid: A hierarchical clustering on principal components analysis identifies unique phenotypes and treatment refractory subsets
2025 · Z. Leibovit-Reiben, A.L. Stockard, et al. · Journal of Investigative Dermatology
Proton therapy has higher false positive rates in PET-CT three months following treatment completion in oropharyngeal cancer
2024 · P. Wistermayer, T. Rath, et al. · International Journal of Particle Therapy
Works count: 17
Citation count: 48
H-index: 4
I10-index: 2
Year
Topic
Type